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Massive unilateral chylous pleural
effusion: a rare initial presentation of
Behcet’s disease
Husain S J, Sadiq F, Zubairi A B, Khan J A

ABSTRACT
Pulmonary manifestations of Behcet’s disease are
not very common and usually include pulmonary
artery aneurysms, central venous thrombosis,
pneumonia and pleurisy. Chylothorax secondary
to superior vena caval obstruction is a rare
complication and has been reported in only a
few cases. We report a case of a 24-year-old
man presenting with massive chylothorax as the
initial presentation of Behcet’s disease that was
successfully treated conservatively.

was normal. There were no visible oro-genital ulcers.
The chest radiograph showed complete opacification
of the right hemithorax (Fig. 1). The serum studies were
unremarkable except for a raised sedimentation rate of
41 mm in the first hour. A diagnostic and therapeutic
pleural tap was done, and 1 L of milky fluid was
aspirated (Fig. 2) The fluid contained total protein
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INTRODUCTION
Behcet’s disease is a multisystem chronic inflammatory
vasculitis of young adults characterised by recurrent
attacks(1,2). Pulmonary complications due to Behcet’s
disease are uncommon. The usual pulmonary involvement
includes thromboangiitis, pulmonary artery aneurysms,
recurrent pneumonias, and pleurisy(1-3). We present a
case where massive chylous pleural effusion was the
presenting feature of Behcet’s disease.

Fig. 1 Chest radiograph shows complete opacification of the
right hemithorax.

CASE REPORT
A 24-year-old man presented to the emergency
department with complaints of progressively-worsening
dyspnoea for three months. He also complained of a
chronic nonproductive cough and low grade fever for the
last two and a half months. His appetite had been poor for
a few weeks and he had lost five kg. His past history was
significant for recurrent painful oral and genital ulcers with
serous discharge. On examination, he was tachypnoeic
and tachycardic. He had distended superficial veins over
the right anterior chest wall, neck and right upper arm.
His right upper extremity and face were swollen. He
also had dullness to percussion and diminished breath
sounds over the right hemithorax. There was evidence
of tender raised nodules on both his legs. The rest of the
systemic examination including the eye examination

Fig. 2 Photograph shows milkiness of the chylous fluid aspirated,
compared with water.
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of 4,300 mg/dL, triglyceride of 1,320 mg/dL and
cholesterol of 32 mg/dL. The cell count of the
fluid showed a white blood cell count of 7,600/L
with a predominance of lymphocytes (95%). The
microbiological and cytopathological studies were all
normal. Doppler ultrasonography of the neck showed
thrombosis of right internal jugular and right subclavian
veins. Spiral computed tomography (CT) of the chest
showed thrombosis of the innominate vein and the
superior vena cava, without any distal embolus.
A diagnosis of Behcet’s disease with chylothorax
secondary to thrombosis of the central veins was
made. The patient was started on oral prednisolone
(Deltacortril, Pfizer, Karachi, Pakistan) at a dose
of 60 mg a day. Anticoagulation was initiated with
enoxaprin (Clexane, Aventis Pharma, Karachi,
Pakistan) at 1 mg/kg twice a day initially, and later
switched to oral warfarin (Marevan, Glaxo Welcome,
Karachi, Pakistan) to maintain an international
normalised ratio (INR) of 2.0-3.0. He was also
advised to keep to a low-fat diet. His symptoms
improved dramatically, and within three months his
dyspnoea and chest radiograph findings resolved
(Fig. 3). Currently, eight months later, he is
asymptomatic and is maintained on 5 mg of
prednisolone and oral warfarin.

Fig. 3 Repeat chest radiograph taken three months later shows
clearing of the effusion.

DISCUSSION
Behcet’s disease is a multisystem chronic
inflammatory disorder of unknown aetiology,
characterised by systemic vasculitis and perivascular
inflammatory infiltrates. Classically, a triad of
symptoms is present, including recurrent aphthous
oral ulcers, uveitis and genital ulcers. Other
organs involved include skin, joints, large vessels,

central nervous system, and gastrointestinal and
pulmonary involvement(1-2). Pulmonary involvement
is uncommon, with studies quoting figures of 1%
to 7.7%(3). Typically, pulmonary artery aneurysms,
arterial and venous thrombosis, pulmonary infarction,
recurrent pneumonias, bronchiolitis obliterans with
organising pneumonia, and pleurisy are the common
pulmonary manifestations.
Our patient presented with a chylous effusion
secondary to thrombosis of the large central veins
including superior vena cava, right innominate,
subclavian and the internal jugular veins. To our
knowledge, chylothorax being the presenting feature
of previously undiagnosed Behcet’s disease, has not
been previously reported. The diagnosis of Behcet’s
disease was made on the basis of the criteria proposed
by the International Study Group for Behcet’s Disease
in 1990(3). This criteria require the presence of oral
ulcers and two additional findings from the following
manifestations: genital ulcers, uveitis, skin lesions
including erythema nodosum, pseudo-folliculitis, or
papulopustular lesions and a positive reaction to a
pathergy test.
Our patient was a young man with a history of
recurrent oral and genital ulcers, erythema nodosum
and central venous thrombosis. Thrombosis of major
vessels is a well-known feature of Behcet’s disease(2,4).
Propagation of peripheral venous thrombosis may
lead to serious vascular complications, such as caval,
portal or hepatic system occlusion. Thrombosis
of superior vena cava may be life-threatening
owing to complications like pulmonary emboli and
chylothorax(4-6). The analysis of the pleural fluid was
consistent with an exudative lymphocyte dominant
effusion, and the chemical analysis was consistent
with chylothorax.
The aetiology of chylous effusion in Behcet’s
disease is uncertain. It has been hypothesised
that thrombosis of the subclavian vein may cause
obstruction of the orifice of the thoracic duct, leading
to increased intraluminal pressure, back pressure in the
communicating vessels and leakage of chyle from
the pleural lymphatics into the pleural space(5,6). The
thrombosis of the superior vena cava also contributes
to the development of the effusion(5,6). Chylothorax
due to central venous thrombosis is very difficult to
treat. Previous reports(4-6) have suggested complete
drainage via a chest tube, followed by chemical
pleurodesis along with anticoagulation and immune
suppressive therapy.
We were able to successfully manage our patient
conservatively with oral steroids, anticoagulation
and a low-fat diet. Within a couple of months, our
patient had a dramatic response to treatment, with
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complete resolution of symptoms and clearing of the
chest radiographical abnormalities. In conclusion,
chylous pleural effusion is a rare presentation of
Behcet’s disease. However, it should be considered
in the differential diagnosis of non-traumatic chylous
pleural effusion. Medical management should be
considered as the first option.
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U.S. ACCREDITED POSTGRADUATE
TRAINING IN INTERNAL MEDICINE
The University of Hawaii welcomes inquiries from physicians seeking postgraduate
training in Internal Medicine. Ours is a high quality fully accredited training program
that features a full array of clinical material, research opportunities and teaching
responsibilities. Several Singaporean physicians have completed training with us, and
are now fully certified by the American Board of Internal Medicine. Our graduates
have also secured prestigious fellowship positions at the NIH, Mayo Clinic, Barnes,
etc., in various subspecialties.
Professor S. Y. Tan (author of the Stamps in Medicine series in the SMJ) will be in
Singapore in November-December 2006 to conduct on-site Q/A sessions and
interviews. If you are interested in an appointment, kindly send a brief resume to
siang@hawaii.edu. You do not need to have completed all of your qualifying exams
(USMLE parts 1 and 2K and 2CS) to meet up with Prof. Tan.

